Administration of anti-CD8 antibody significantly reduced CD8+ cells in spleens and tumor-bearing SMG tissues in Atg5flox/flox mice, while the percentage of CD4+ cells remained unaffected (Figure S5B). The gene discussed is CD4; the disease is neoplasm.